Form 144: Proposed sale of restricted CVS shares

Morgan Stanley Smith Barney LLC Executive Financial Services submitted a Form 144 notice reporting proposed sales of Common stock tied to restricted stock awards with multiple grant dates.

Rhea-AI Filing Summary

Morgan Stanley Smith Barney LLC Executive Financial Services submitted a Form 144 notice reporting proposed sales of Common stock tied to restricted stock awards with multiple grant dates. The notice lists proposed quantities by grant date, including 20,229 and 20,449 share lots and additional smaller tranches, with transaction venue noted as NYSE.

Key Figures

Filer address: 1 New York Plaza, 8th Floor Trading venue: NYSE Restricted shares (08/31/2023): 20,229 shares +4 more

7 metrics

Filer address 1 New York Plaza, 8th Floor Filer: Morgan Stanley Smith Barney LLC Executive Financial Services

Trading venue NYSE Designated market for proposed sales

Restricted shares (08/31/2023) 20,229 shares Grant date 08/31/2023

Restricted shares (08/31/2024) 20,185 shares Grant date 08/31/2024

Restricted shares (04/01/2025) 3,089 shares Grant date 04/01/2025

Restricted shares (08/31/2025) 20,449 shares Grant date 08/31/2025

Restricted shares (04/01/2026) 2,477 and 3,122 shares Two line items dated 04/01/2026

Key Terms

Restricted Stock, Form 144, Issuer

3 terms

Restricted Stock financial

"Rows label entries as "Restricted Stock" tied to grant dates"

Shares granted to an individual that carry limits on transfer or sale until certain conditions are met, such as staying with the company for a set time or hitting performance targets. Think of them as a locked gift that gradually opens; for investors they matter because they affect how many shares may enter the market later, signal management incentives and potential dilution, and reveal confidence in future company performance.

Form 144 regulatory

"Header identifies the submission as form type 144 and lists securities to be sold"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

Issuer financial

"Table column shows "Issuer" as the source for the restricted shares"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the Form 144 for CVS list?

The Form 144 lists proposed sales of Common stock associated with restricted stock awards. It includes grant dates and per‑grant share counts such as 20,229 and 20,449, and identifies the trading market as NYSE.

Who is the filer on the Form 144?

The filer is Morgan Stanley Smith Barney LLC Executive Financial Services, listed with an address at 1 New York Plaza, 8th Floor, New York, NY 10004, appearing as the broker/dealer handling the proposed dispositions.

Which grant dates and share amounts are shown on the notice?

The notice shows multiple grant dates: 08/31/2023, 08/31/2024, 04/01/2025, 08/31/2025, and 04/01/2026, with corresponding share counts including 20,229, 20,185, 3,089, 20,449, 2,477, and 3,122.

Does the filing state proceeds or sale timing?

The excerpt identifies proposed sale quantities and dates tied to restricted stock awards but does not state sale prices or exact execution timing. The market listed is NYSE; further transactional details are not provided in the excerpt.

Are these shares described as restricted or unrestricted?

The shares are identified as Restricted Stock in the rows shown, with the filer and issuer listed. The entries indicate the shares originate from issuer awards on the specified grant dates.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 05/08/2026 - 04:36 PM EDT Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001872827
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	CVS HEALTH CORPORATION
SEC File Number	001-01011
Address of Issuer	One CVS Drive Woonsocket RHODE ISLAND 02895
Phone	(401) 765-1500
Name of Person for Whose Account the Securities are To Be Sold	TILAK MANDADI
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	69551	6230719.38	1275927307	05/08/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	08/31/2023	Restricted Stock	Issuer			20229	08/31/2023	Not Applicable
Common	08/31/2024	Restricted Stock	Issuer			20185	08/31/2024	Not Applicable
Common	04/01/2025	Restricted Stock	Issuer			3089	04/01/2025	Not Applicable
Common	08/31/2025	Restricted Stock	Issuer			20449	08/31/2025	Not Applicable
Common	04/01/2026	Restricted Stock	Issuer			2477	04/01/2026	Not Applicable
Common	04/01/2026	Restricted Stock	Issuer			3122	04/01/2026	Not Applicable

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks
Date of Notice	05/08/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Tilak Mandadi
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)